The Report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) – Forecasts to 2021.”
The Varicose Vein Treatment Market in North America and Europe is projected to reach to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, growing at a CAGR of 6.9% from 2016 to 2021.
Download a FREE Pdf Broucher @:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107
Objectives of the study are:
- To define, describe, and forecast the varicose vein treatment market in North America and Europe on the basis of mode of treatment, products, and regions
- To provide detailed information regarding major factors influencing the growth of the varicose vein treatment market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others
This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.
The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations.
To speak to our analyst for a discussion on the above findings, click @:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=22524107